News Releases

August 9, 2021
Global rights to registrational-stage ophthalmology drug return to Molecular Partners Improvements in manufacturing and formulation have been made and tested in  pre-clinical models with the potential to overcome inflammatory side effects Ongoing research discovery alliance with AbbVie in
Displaying 71 - 80 of 198
* These releases may contain price sensitive information